KAYLA LAPP: Open Payments
NPI 1124877287 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 31 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $801
Food & beverage: $623Education: $178
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $221 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $171 |
| ABBVIE INC. | 8 | $169 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Janssen Biotech, Inc. | 4 | $70 |
| LifeNet Health | 1 | $44 |
| UCB, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, TREMFYA, ILUMYA, RINVOQ, TheraGenesis Wound Matrix, Odomzo.
Industry payments across PA — which companies pay providers there.
